Lv1
20 积分 2025-01-12 加入
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
4个月前
已完结
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target Trial
6个月前
已完结
Comparative effectiveness of GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors on liver outcomes in metabolic dysfunction-associated steatotic liver disease: A retrospective cohort study
7个月前
已完结
Association of chronic kidney disease and type 2 diabetes mellitus with metabolic dysfunction-associated steatotic liver disease and liver fibrosis assessed by transient elastography: a cross-sectional study based on NHANES 2017-2020
7个月前
已关闭
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
8个月前
已完结
Association between body roundness index and new-onset stroke risk in middle-aged and older adults with varying glucose metabolism status: A longitudinal study using CHARLS data
1年前
已关闭
皖公网安备34019202002308
